Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
23-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #2602
advertisement
Frontiers in pharmacology
13
Showing records 1 to 13 |
Display all abstracts in
Frontiers in pharmacology
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Huang L
Frontiers in pharmacology
2022; 13: 990401
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Brandt AL
Frontiers in pharmacology
2022; 13: 919605
106221
Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Zhou L
Frontiers in pharmacology
2022; 13: 1015338
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Ye Q
Frontiers in pharmacology
2022; 13: 990401
106221
Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Zhan W
Frontiers in pharmacology
2022; 13: 1015338
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Garai S; Zagzoog A
Frontiers in pharmacology
2022; 13: 919605
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Lan C
Frontiers in pharmacology
2022; 13: 990401
106221
Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Wei X
Frontiers in pharmacology
2022; 13: 1015338
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Hurst DP
Frontiers in pharmacology
2022; 13: 919605
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Wang X
Frontiers in pharmacology
2022; 13: 990401
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Stevenson LA
Frontiers in pharmacology
2022; 13: 919605
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Zhu Y
Frontiers in pharmacology
2022; 13: 990401
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Pertwee RG; Imler GH; Reggio PH; Thakur GA; Laprairie RB
Frontiers in pharmacology
2022; 13: 919605
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement